UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 11, 2024 OptimizeRx Corporation (Exact name of registrant as specified in charter) Nevada 001-38543 26-1265381 (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No. ) 260 Charles Street, Suite 302, Waltham, MA 02453 (Address of principal ...